ClinicalTrials.Veeva

Menu

Bioavailability of Vitamin D Photoisomers From UVB-exposed Button Mushrooms

M

Martin-Luther-Universität Halle-Wittenberg

Status

Not yet enrolling

Conditions

Dietary Exposure
Safety Issues

Treatments

Dietary Supplement: UVB-exposed button mushrooms

Study type

Interventional

Funder types

Other

Identifiers

NCT05668832
UHalle 2022-123

Details and patient eligibility

About

The European Food Safety Authority has approved many applications for UVB light treated foods (e.g. UVB-exposed button mushrooms) in the last years. The UVB light treatment is used to increase the vitamin D content in foods and improve the vitamin D status of subjects. However, UVB irradiation is accompanied by the formation of vitamin D photoisomers such as lumisterol and tachysterol. The current study aims to investigated whether these vitamin D photoisomers can enter the circulation and are metabolised in humans that consume UVB-treated mushrooms.

Full description

according to protocol

Enrollment

36 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy subjects
  • Age between 18 and 65 years
  • Body Mass Index in the range of 18.5 to 29.9 kg/m2

Exclusion criteria

  • Acute or chronic illnesses (high blood pressure, heart disease, diabetes, kidney disease, liver disease, alcohol dependence, etc.)
  • Taking medication (except oral contraceptives)
  • Pregnancy or breastfeeding
  • Food intolerances or allergies to mushrooms and dairy products
  • Smokers
  • Visits to solariums or previous holidays in southern countries or in the Alps or other high mountains
  • Participation in another study
  • Blood donation during the last 2 months before the start of the study
  • Dieting
  • Severe weight loss or weight loss (≥ 3 kg) within the last month

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

36 participants in 2 patient groups, including a placebo group

oral intake of UVB-exposed mushrooms
Experimental group
Description:
Daily intake of 500 g of UVB-exposed button mushrooms over 7 days (provided as mushroom cream soup) and blood sampling (at baseline, 3 h postprandial, 6 h postprandial and at day 8)
Treatment:
Dietary Supplement: UVB-exposed button mushrooms
oral intake of non-UVB-exposed mushrooms
Placebo Comparator group
Description:
Daily intake of 500 g of non-UVB-exposed button mushrooms over 7 days (provided as mushroom cream soup) and blood sampling (at baseline, 3 h postprandial, 6 h postprandial and at day 8)
Treatment:
Dietary Supplement: UVB-exposed button mushrooms

Trial contacts and locations

0

Loading...

Central trial contact

Gabriele I Stangl, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems